IMPROVING ONCOLOGY ANALYSIS WITH BUILT-IN KRAS ASSAY PROVIDERS AND RAS ASSAYS

during the quickly evolving field of oncology exploration, correct and efficient mutation screening is very important for creating qualified therapies. The KRAS solutions System performs a pivotal role On this landscape by supplying comprehensive methods for KRAS mutation profiling and Assessment. KRAS mutations, present in close to ninety five% of